Cargando…

Calcineurin A beta deficiency ameliorates HFD-induced hypothalamic astrocytosis in mice

Astrocytosis is a reactive process involving cellular, molecular, and functional changes to facilitate neuronal survival, myelin preservation, blood brain barrier function and protective glial scar formation upon brain insult. The overall pro- or anti-inflammatory impact of reactive astrocytes appea...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfuhlmann, Katrin, Schriever, Sonja C., Legutko, Beata, Baumann, Peter, Harrison, Luke, Kabra, Dhiraj G., Baumgart, Emily Violette, Tschöp, Matthias H., Garcia-Caceres, Cristina, Pfluger, Paul T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806488/
https://www.ncbi.nlm.nih.gov/pubmed/29422055
http://dx.doi.org/10.1186/s12974-018-1076-x
_version_ 1783299144957296640
author Pfuhlmann, Katrin
Schriever, Sonja C.
Legutko, Beata
Baumann, Peter
Harrison, Luke
Kabra, Dhiraj G.
Baumgart, Emily Violette
Tschöp, Matthias H.
Garcia-Caceres, Cristina
Pfluger, Paul T.
author_facet Pfuhlmann, Katrin
Schriever, Sonja C.
Legutko, Beata
Baumann, Peter
Harrison, Luke
Kabra, Dhiraj G.
Baumgart, Emily Violette
Tschöp, Matthias H.
Garcia-Caceres, Cristina
Pfluger, Paul T.
author_sort Pfuhlmann, Katrin
collection PubMed
description Astrocytosis is a reactive process involving cellular, molecular, and functional changes to facilitate neuronal survival, myelin preservation, blood brain barrier function and protective glial scar formation upon brain insult. The overall pro- or anti-inflammatory impact of reactive astrocytes appears to be driven in a context- and disease-driven manner by modulation of astrocytic Ca(2+) homeostasis and activation of Ca(2+)/calmodulin-activated serine/threonine phosphatase calcineurin. Here, we aimed to assess whether calcineurin is dispensable for astrocytosis in the hypothalamus driven by prolonged high fat diet (HFD) feeding. Global deletion of calcineurin A beta (gene name: Ppp3cb) led to a decrease of glial fibrillary acidic protein (GFAP)-positive cells in the ventromedial hypothalamus (VMH), dorsomedial hypothalamus (DMH), and arcuate nucleus (ARC) of mice exposed chronically to HFD. The concomitant decrease in Iba1-positive microglia in the VMH further suggests a modest impact of Ppp3cb deletion on microgliosis. Pharmacological inhibition of calcineurin activity by Fk506 had no impact on IBA1-positive microglia in hypothalami of mice acutely exposed to HFD for 1 week. However, Fk506-treated mice displayed a decrease in GFAP levels in the ARC. In vivo effects could not be replicated in cell culture, where calcineurin inhibition by Fk506 had no effect on astrocytic morphology, astrocytic cell death, GFAP, and vimentin protein levels or microglia numbers in primary hypothalamic astrocytes and microglia co-cultures. Further, adenoviral overexpression of calcineurin subunit Ppp3r1 in primary glia culture did not lead to an increase in GFAP fluorescence intensity. Overall, our results point to a prominent role of calcineurin in mediating hypothalamic astrocytosis as response to acute and chronic HFD exposure. Moreover, discrepant findings in vivo and in cell culture indicate the necessity of studying astrocytes in their “natural” environment, i.e., preserving an intact hypothalamic microenvironment with neurons and non-neuronal cells in close proximity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-018-1076-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5806488
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58064882018-02-15 Calcineurin A beta deficiency ameliorates HFD-induced hypothalamic astrocytosis in mice Pfuhlmann, Katrin Schriever, Sonja C. Legutko, Beata Baumann, Peter Harrison, Luke Kabra, Dhiraj G. Baumgart, Emily Violette Tschöp, Matthias H. Garcia-Caceres, Cristina Pfluger, Paul T. J Neuroinflammation Short Report Astrocytosis is a reactive process involving cellular, molecular, and functional changes to facilitate neuronal survival, myelin preservation, blood brain barrier function and protective glial scar formation upon brain insult. The overall pro- or anti-inflammatory impact of reactive astrocytes appears to be driven in a context- and disease-driven manner by modulation of astrocytic Ca(2+) homeostasis and activation of Ca(2+)/calmodulin-activated serine/threonine phosphatase calcineurin. Here, we aimed to assess whether calcineurin is dispensable for astrocytosis in the hypothalamus driven by prolonged high fat diet (HFD) feeding. Global deletion of calcineurin A beta (gene name: Ppp3cb) led to a decrease of glial fibrillary acidic protein (GFAP)-positive cells in the ventromedial hypothalamus (VMH), dorsomedial hypothalamus (DMH), and arcuate nucleus (ARC) of mice exposed chronically to HFD. The concomitant decrease in Iba1-positive microglia in the VMH further suggests a modest impact of Ppp3cb deletion on microgliosis. Pharmacological inhibition of calcineurin activity by Fk506 had no impact on IBA1-positive microglia in hypothalami of mice acutely exposed to HFD for 1 week. However, Fk506-treated mice displayed a decrease in GFAP levels in the ARC. In vivo effects could not be replicated in cell culture, where calcineurin inhibition by Fk506 had no effect on astrocytic morphology, astrocytic cell death, GFAP, and vimentin protein levels or microglia numbers in primary hypothalamic astrocytes and microglia co-cultures. Further, adenoviral overexpression of calcineurin subunit Ppp3r1 in primary glia culture did not lead to an increase in GFAP fluorescence intensity. Overall, our results point to a prominent role of calcineurin in mediating hypothalamic astrocytosis as response to acute and chronic HFD exposure. Moreover, discrepant findings in vivo and in cell culture indicate the necessity of studying astrocytes in their “natural” environment, i.e., preserving an intact hypothalamic microenvironment with neurons and non-neuronal cells in close proximity. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12974-018-1076-x) contains supplementary material, which is available to authorized users. BioMed Central 2018-02-08 /pmc/articles/PMC5806488/ /pubmed/29422055 http://dx.doi.org/10.1186/s12974-018-1076-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Short Report
Pfuhlmann, Katrin
Schriever, Sonja C.
Legutko, Beata
Baumann, Peter
Harrison, Luke
Kabra, Dhiraj G.
Baumgart, Emily Violette
Tschöp, Matthias H.
Garcia-Caceres, Cristina
Pfluger, Paul T.
Calcineurin A beta deficiency ameliorates HFD-induced hypothalamic astrocytosis in mice
title Calcineurin A beta deficiency ameliorates HFD-induced hypothalamic astrocytosis in mice
title_full Calcineurin A beta deficiency ameliorates HFD-induced hypothalamic astrocytosis in mice
title_fullStr Calcineurin A beta deficiency ameliorates HFD-induced hypothalamic astrocytosis in mice
title_full_unstemmed Calcineurin A beta deficiency ameliorates HFD-induced hypothalamic astrocytosis in mice
title_short Calcineurin A beta deficiency ameliorates HFD-induced hypothalamic astrocytosis in mice
title_sort calcineurin a beta deficiency ameliorates hfd-induced hypothalamic astrocytosis in mice
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806488/
https://www.ncbi.nlm.nih.gov/pubmed/29422055
http://dx.doi.org/10.1186/s12974-018-1076-x
work_keys_str_mv AT pfuhlmannkatrin calcineurinabetadeficiencyameliorateshfdinducedhypothalamicastrocytosisinmice
AT schrieversonjac calcineurinabetadeficiencyameliorateshfdinducedhypothalamicastrocytosisinmice
AT legutkobeata calcineurinabetadeficiencyameliorateshfdinducedhypothalamicastrocytosisinmice
AT baumannpeter calcineurinabetadeficiencyameliorateshfdinducedhypothalamicastrocytosisinmice
AT harrisonluke calcineurinabetadeficiencyameliorateshfdinducedhypothalamicastrocytosisinmice
AT kabradhirajg calcineurinabetadeficiencyameliorateshfdinducedhypothalamicastrocytosisinmice
AT baumgartemilyviolette calcineurinabetadeficiencyameliorateshfdinducedhypothalamicastrocytosisinmice
AT tschopmatthiash calcineurinabetadeficiencyameliorateshfdinducedhypothalamicastrocytosisinmice
AT garciacacerescristina calcineurinabetadeficiencyameliorateshfdinducedhypothalamicastrocytosisinmice
AT pflugerpault calcineurinabetadeficiencyameliorateshfdinducedhypothalamicastrocytosisinmice